[Table/Fig-2]:
Overview of different non-viral vector delivery methods
Delivery methods | Key Mechanism | Tissue on which it is effective | Advantage | Disadvantage |
---|---|---|---|---|
Naked plasma/Plasmid DNA[p DNA] –Direct delivery | Endocytosis | Muscle, skin, liver, cardiac muscle and solid tumour. | Safety. Simplicity. | Low transfection efficiency. |
Gene Gun | High pressure helium stream | Ovarian cancer cell line[invitro and in vivo preclinical model] | Flexibility. Low cytotoxicity. Good efficiency. | Shallow penetration |
Electroporation | Enhancement of cell membrane permeability | Skin, muscle. | Good efficiency. Repeatable. | Tissue damage. Accessibility of electrodes to internal organ are limited. |
Ultrasound + micro bubble | Enhancement of cell membrane permeability | Brain, cornea, kidney, peritoneal cavity, muscle, heart, vascular cells. | Safety. Flexibility. | Low efficiency. |
Magnetofection | Pinocytosis and endocytosis | primary cells and cells difficult to transfect by other methods[only invitro] | Flexibility. Low cytotoxicity. | Transient transfection. |
Inorganic molecules | Endocytosis | Invitro | Easy Production Storage stability. Surface functionalization. | Low efficiency |
Type of vector | Key mechanism | Target tissue | Advantage | Disadvantage |
Lipoplexes[Lipid based] | Endocytosis, DNA condensation, | Airway epithelial cells, endothelial cells, hepatocytes, muscle cells. | Safety Low cytotoxicity | Low to medium efficiency Some results immunogenicity. |
Polyplexes and Dendrimers | Endocytosis, DNA condensation, protein sponge effect | Lung, oral cavity. | Low immunogenicity Fair efficiency | Complement activation Low efficiency Cytotoxicity. |